This study demonstrated that overexpressed SNHG3 was significantly associated with poor survival, including OS, DFS, and RFS and worse clinical outcomes, including clinical stage, histological grade, distant metastasis, and lymph node metastasis in human cancers. The gene discussed is SNHG3; the disease is metastatic malignant neoplasm in the lymph nodes.